Evidence map›Paper›PMID 32944145›Full record

ArticleACS medicinal chemistry letters2020

Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P

Zili Xiao, Michael G Yang, T G Murali Dhar, Hai-Yun Xiao, John L Gilmore, David Marcoux, Kim W McIntyre, Tracy L Taylor, Hong Shi, Paul C Levesque and 10 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Zili XiaoResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Michael G YangResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
T G Murali DharResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Hai-Yun XiaoResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
John L GilmoreResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
David MarcouxResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Kim W McIntyreResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Tracy L TaylorResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Hong ShiResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Paul C LevesqueResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Anthony M MarinoResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Georgia CorneliusResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Arvind MathurResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Ding Ren ShenResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Mary Ellen CvijicResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Lois D Lehman-McKeemanResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Huadong SunResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Jenny H XieResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Percy H CarterResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Alaric J DyckmanResearch and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
Bristol-Myers Squibb (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efforts aimed at increasing the in vivo potency and reducing the elimination half-life of

Identifiers

PMID32944145
PMCPMC7488280
OpenAlexW3048867077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.